Rare diseases
Investigational molecules
Locations
1350 Avenue Of The Americas Fl 23rd, 10019-4801, United States
Promontory Therapeutics Inc. is focused on metastatic castrate resistant prostate cancer, with clinical activity centered on advanced disease settings where treatment options are limited and disease control remains a key objective.
The sponsor’s research interest in this area reflects an emphasis on therapies for progressive prostate malignancy and related advanced oncologic disease.
Promontory Therapeutics Inc. runs clinical trials in conditions such as Hormone-refractory prostate cancer, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
